Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation.

There are few biomarkers able to forecast new thrombotic events in patients with AF. In this framework, microRNAs have emerged as critical players in cardiovascular biology. In particular, miR-146a-5p is recognised as an important negative regulator of inflammation.